We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-15.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.72B
AUM Growth
-$127M
Cap. Flow
+$291M
Cap. Flow %
16.93%
Top 10 Hldgs %
29.42%
Holding
147
New
37
Increased
70
Reduced
4
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 24.49%
3 Consumer Discretionary 14.42%
4 Industrials 7.04%
5 Real Estate 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBC
26
DELISTED
WABCO HOLDINGS INC.
WBC
$26.8M 1.56%
255,600
STLD icon
27
Steel Dynamics
STLD
$36.2B
$26M 1.51%
1,515,500
+303,600
+25% +$5.88M
COLL icon
28
Collegium Pharmaceutical
COLL
$1.17B
$21.6M 1.25%
975,418
+229,616
+31% +$4.15M
IDTI
29
DELISTED
Integrated Device Technology I
IDTI
$20.9M 1.21%
1,027,800
CPN
30
DELISTED
Calpine Corporation
CPN
$20.5M 1.19%
1,401,800
+598,200
+74% +$9.82M
BWA icon
31
BorgWarner
BWA
$13.2B
$20.5M 1.19%
558,912
+143,022
+34% +$5.95M
PTLA
32
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$20.5M 1.19%
479,900
+74,600
+18% +$3.6M
CMRX
33
DELISTED
Chimerix, Inc.
CMRX
$20.4M 1.19%
534,500
+43,700
+9% +$2.16M
SUNE
34
DELISTED
SUNEDISON, INC COM
SUNE
$20.3M 1.18%
2,827,600
+1,254,000
+80% +$22.5M
IMPV
35
DELISTED
Imperva, Inc.
IMPV
$20.3M 1.18%
309,700
-20,000
-6% -$1.33M
MDVN
36
DELISTED
MEDIVATION, INC.
MDVN
$19.9M 1.15%
467,400
+51,000
+12% +$2.53M
IPHI
37
DELISTED
INPHI CORPORATION
IPHI
$19.2M 1.12%
799,100
CBI
38
DELISTED
Chicago Bridge & Iron Nv
CBI
$18.6M 1.08%
468,200
FPRX
39
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$17.9M 1.04%
1,164,900
+207,000
+22% +$4.45M
TERP
40
DELISTED
TerraForm Power, Inc
TERP
$17.8M 1.03%
+1,249,550
New +$33.5M
AGIO icon
41
Agios Pharmaceuticals
AGIO
$1.95B
$17.3M 1%
244,900
+78,700
+47% +$7.69M
SCTY
42
DELISTED
SolarCity Corporation
SCTY
$15.9M 0.93%
372,800
MGNX icon
43
MacroGenics
MGNX
$240M
$15.2M 0.88%
709,600
+87,100
+14% +$2.73M
NVAX icon
44
Novavax
NVAX
$1.22B
$14.8M 0.86%
104,875
+9,440
+10% +$2.12M
SPWR
45
DELISTED
SunPower Corporation Common Stock
SPWR
$12.9M 0.75%
+979,876
New +$15.8M
STKL
46
DELISTED
SunOpta
STKL
$12.6M 0.73%
2,590,200
+1,300,000
+101% +$11.8M
LLTC
47
DELISTED
Linear Technology Corp
LLTC
$11.8M 0.69%
292,600
UFS
48
DELISTED
DOMTAR CORPORATION (New)
UFS
$11.7M 0.68%
328,400
+109,800
+50% +$4.34M
ACAD icon
49
Acadia Pharmaceuticals
ACAD
$4.55B
$10.8M 0.63%
326,700
+55,600
+21% +$2.31M
EOG icon
50
EOG Resources
EOG
$77.5B
$10.5M 0.61%
144,800

Similar funds

Eventide Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Eventide Asset Management held 147 positions worth $1.72B, down 6.9% from $1.85B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $291M of net new capital in Q3 2015, opening 37 new positions and adding to 70 existing holdings. Its largest new stake was TerraForm Power, Inc: 1,249,550 shares worth $17.8M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Tetraphase Pharmaceuticals, Inc., an estimated $4.26M trimmed.

  • Eventide Asset Management's largest Q3 2015 buy was TerraForm Power, Inc: 1,249,550 shares worth $17.8M.
  • Eventide Asset Management added most to Palo Alto Networks in Q3 2015, an estimated $23.1M increase.
  • Eventide Asset Management's biggest Q3 2015 reduction was Tetraphase Pharmaceuticals, Inc., cutting an estimated $4.26M.
  • Eventide Asset Management fully exited Mandiant, Inc. Common Stock in Q3 2015, selling an estimated $40.5M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $1.72B portfolio in Q3 2015.
  • Eventide Asset Management opened 37 new positions and closed 12 in Q3 2015.
  • Eventide Asset Management's portfolio value fell 6.9% quarter-over-quarter to $1.72B.

Based on Eventide Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.